Navigation Links
Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
Date:7/31/2008

DUBLIN, Ohio, July 31 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced a three-year agreement with Prime Therapeutics, one of the nation's leading pharmacy benefit managers, to serve as its primary supply chain partner for branded and generic pharmaceuticals, effective August 1.

Prime Therapeutics managed more than $8.2 billion in prescription drug spend in 2007, and currently serves approximately 14.6 million members through Blue Cross and Blue Shield Plans, employer and union groups and third-party administrators.

"We look forward to delivering the pharmaceutical supply chain services that will help Prime Therapeutics continue to efficiently and effectively serve its patients' medication needs," said Mike Kaufmann, group president of Healthcare Supply Chain Services - Pharmaceutical for Cardinal Health. "This agreement is an excellent example of our commitment to building flexible, mutually beneficial partnerships with our customers that also enable us to grow our pharmaceutical distribution business."

Cardinal Health will also offer Prime Therapeutics additional supply chain optimization services to help improve its operational efficiency.

"This innovative new partnership will provide us with the benefits of buying through a drug wholesaler and the insights and expertise of direct generics buying," said Tim Dickman, Prime Therapeutics CEO. "Cardinal Health was selected as our primary distributor because they offer the experience, value-added services and flexibility that we need to continue to deliver quality, cost-efficient prescription drug benefits to our customers."

About Prime Therapeutics

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) electronic infection surveillance service, VIASYS(R) respiratory care products and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com.


'/>"/>
SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
2. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
3. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
4. Nanotechs health, environmental impacts worry scientists and the public
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. IBF/LifeScience Alley MedTech Investing Conference Adds Ashley Boam, Acting Deputy Director for Science and Review Policy, Office of Device Evaluation, Center for Devices and Radiological Health, FDA
7. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
8. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
9. Primera Biosystems Raises $21 Million in Series B Private Round
10. Prime Therapeutics Receives VIPPS Accreditation
11. Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):